Literature DB >> 9098184

Biologic synergism and parallelism.

J Darroch1.   

Abstract

In epidemiologic studies of two binary exposure factors, much attention has been given to the concept of synergism of the factors. The leading dictionary of epidemiology offers two definitions of synergism, one of which this author labels statistical and the other biologic. The epidemiologic literature has been largely concerned with statistical synergism, which is typically measured using additive or multiplicative interaction. This paper focuses on biologic synergism, on the related concept of biologic parallelism, and on the question of how much information can be gleaned about population amounts of biologic synergism and parallelism--information which is of vital interest to epidemiologists. A fundamental identity equates the difference between the amounts of biologic synergism and parallelism to the additive interaction. Two biologic models, the multistage model and the no-hit or immunity model, enhance the interpretation of multiplicative interaction as a measure of statistical synergism, but it is pointed out here that, unfortunately, both models incorporate the strong assumption that there is no parallelism. A third model, the single-hit or vulnerability model, makes the even stronger assumption that there is no biologic synergism and consequently that the additive interaction is equal to minus the amount of parallelism. A consequence of this fact is that a link which has been perceived in the literature to exist between the single-hit model and the additive interaction is false.

Mesh:

Year:  1997        PMID: 9098184     DOI: 10.1093/oxfordjournals.aje.a009164

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  37 in total

1.  Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood.

Authors:  Philip R Nielsen; Thomas M Laursen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2011-10-20       Impact factor: 9.306

2.  The environment and schizophrenia.

Authors:  Jim van Os; Gunter Kenis; Bart P F Rutten
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  Interaction - Epidemiology's Brinkmanship.

Authors:  Alfredo Morabia
Journal:  Epidemiol Methods       Date:  2014-11-07

4.  Evaluation of non-response bias in mental health determinants and outcomes in a large sample of pre-adolescents.

Authors:  Andrea F de Winter; Albertine J Oldehinkel; René Veenstra; J Agnes Brunnekreef; Frank C Verhulst; Johan Ormel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 5.  Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction.

Authors:  Ruud van Winkel; Nicholas C Stefanis; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2008-08-20       Impact factor: 9.306

6.  A sufficient cause based approach to the assessment of mediation.

Authors:  Danella M Hafeman
Journal:  Eur J Epidemiol       Date:  2008-09-17       Impact factor: 8.082

7.  A conditional synergy index to assess biological interaction.

Authors:  Ronja Foraita
Journal:  Eur J Epidemiol       Date:  2009-08-08       Impact factor: 8.082

8.  Evidence that the urban environment specifically impacts on the psychotic but not the affective dimension of bipolar disorder.

Authors:  Nil Kaymaz; Lydia Krabbendam; Ron de Graaf; Willem Nolen; Margreet Ten Have; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-07-03       Impact factor: 4.328

9.  Should gestational weight gain recommendations be tailored by maternal characteristics?

Authors:  Lisa M Bodnar; Jennifer A Hutcheon; Robert W Platt; Katherine P Himes; Hyagriv N Simhan; Barbara Abrams
Journal:  Am J Epidemiol       Date:  2011-06-01       Impact factor: 4.897

10.  Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.

Authors:  Cécile Henquet; Lydia Krabbendam; Janneke Spauwen; Charles Kaplan; Roselind Lieb; Hans-Ulrich Wittchen; Jim van Os
Journal:  BMJ       Date:  2004-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.